Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
TCI Gene Enhancing Malaysia's Preventive Healthcare In Collaboration With ALPRO Pharmacy 2024-03-28 12:30
XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024 2024-03-28 09:05
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 2024-03-28 07:01
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY 2024-03-27 23:26
Ascentage Pharma Announces 2023 Annual Results 2024-03-27 22:30
CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates 2024-03-27 22:00
Zepp Health to Honor Marathon Icon Kelvin Kiptum with Amazfit Cheetah Pro Commemorative Edition Watch and Foundation Support 2024-03-27 21:00
CARsgen Announced 2023 Annual Results 2024-03-27 20:50
YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean 2024-03-27 20:00
Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development 2024-03-27 20:00
Vantage Foundation partners Instituto Claret to uplift underprivileged in Brazil 2024-03-27 18:05
Waterdrop declared a special cash dividend, the aggregate payment of which amounted to approximately US$15 million 2024-03-27 14:35
Indonesia's Ministry of Health and Tanoto Foundation Collaborate to Improve the Nation's Primary Health Care Services 2024-03-27 14:00
Nutrition Expert Shares Top Eight Sustainable and Affordable Seafood Choices 2024-03-27 13:31
Unlocking Global Beauty: Exploring Innovations in International Travel Beauty Business 2024-03-27 12:31
Waterdrop declared a special cash dividend, the aggregate payment of which amounted to approximately US$15 million 2024-03-27 12:11
Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project 2024-03-27 11:24
Innovative strides in medical-grade TPUs: ICP DAS-BMP to introduce groundbreaking solutions at CMEF and Medtec Japan 2024-03-27 09:20
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy 2024-03-27 08:00
Beauty Industry's Largest Acquisition to Date in 2024, Beauty Farm Acquires 70% of Naturade, China's Second-Largest Industry Player 2024-03-27 07:30
1 110 111 112 113 114 1597